|
1
|
Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells.
|
Am J Pathol
|
2009
|
1.75
|
|
2
|
E-cadherin/β-catenin complex and the epithelial barrier.
|
J Biomed Biotechnol
|
2011
|
1.61
|
|
3
|
IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis.
|
J Am Soc Nephrol
|
2010
|
1.44
|
|
4
|
By homing to the kidney, activated macrophages potently exacerbate renal injury.
|
Am J Pathol
|
2008
|
1.11
|
|
5
|
Characterization of murine macrophages from bone marrow, spleen and peritoneum.
|
BMC Immunol
|
2013
|
1.05
|
|
6
|
IL-25 induces M2 macrophages and reduces renal injury in proteinuric kidney disease.
|
J Am Soc Nephrol
|
2011
|
0.96
|
|
7
|
Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases.
|
World J Nephrol
|
2013
|
0.91
|
|
8
|
Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease.
|
Kidney Int
|
2012
|
0.85
|
|
9
|
Association of β-catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF-β1.
|
J Cell Sci
|
2012
|
0.84
|
|
10
|
DEC205-DC targeted DNA vaccines to CX3CR1 and CCL2 are potent and limit macrophage migration.
|
Int J Clin Exp Med
|
2012
|
0.78
|
|
11
|
DNA vaccine encoding CD40 targeted to dendritic cells in situ prevents the development of Heymann nephritis in rats.
|
Kidney Int
|
2012
|
0.77
|